Mirada Solutions Announces PETconnect(TM) Product Integration Pathway for PACS Vendors

Share Name	Share Symbol	Market	Type
Cti Molecular Imaging - Common Stock (MM)	NASDAQ:CTMI	NASDAQ	Common Stock

Cti Molecular Imaging (NASDAQ:CTMI)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Cti Molecular Imaging Charts.

Mirada Solutions Announces PETconnect(TM) Product Integration Pathway for PACS Vendors OXFORD, England, June 24 /PRNewswire-FirstCall/ -- Mirada Solutions Ltd. (a subsidiary of CTI Molecular Imaging, Inc.), leaders in software for molecular imaging, have announced the availability of a new product integration toolkit -- PETconnnect(TM). PETconnect is a general purpose library interface to Mirada's complete range of imaging applications for PET and PET/CT, multi-modality image fusion, functional imaging and radiation therapy. Imaging OEMs and PACS vendors may choose from a variety of interfaces to quickly and cost effectively integrate Mirada's products into a host system. Integration options include Java, CORBA and ActiveX/COM interfaces, as well as conventional operating system and DICOM-level approaches. Martin Smyth, Vice President for Engineering at Mirada Solutions, commented, "Over the past 5 years, Mirada has integrated products into platforms offered by many of the leading companies in diagnostic imaging and radiation therapy. PETconnect(TM) combines our OEM customer experience and engineering expertise to offer a really streamlined way for vendors -- particularly PACS companies -- to integrate our products." Christian P. Behrenbruch Ph.D., President of Mirada Solutions, stated, "PETconnect plays an important role for CTI by offering a highly distributed software application base to be marketed through the PET probe distribution capabilities of PETNET. Mirada's versatility to serve a diverse range of current and future PET users in many different segments of the diagnostic imaging and therapeutic domain is a key to this strategy." PETconnect(TM) has been already used as a product integration pathway with a number of vendors, including Siemens, Toshiba, Hitachi, Vital Images and Sectra AB. About Mirada Solutions: Mirada Solutions Limited, a wholly owned subsidiary of CTI Molecular Imaging, is a leading developer of software and analytical tools for medical imaging workstations, OEM imaging platforms and pharmaceutical applications. Mirada's unique products aid in better detection, diagnosis and management of disease through the application of powerful algorithms, quantification tools and image analysis. Additional information is available at http://www.mirada-solutions.com/ . About CTI Molecular Imaging: CTI Molecular Imaging, Inc. is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, cardiac disease and neurological disorders. Additional information is available at: http://www.ctimi.com/ . Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as "believe," "assume," "expect," "anticipate," "intend," "estimate" or similar expressions, and any other statements that necessarily depend on future events. Forward-looking statements involve a number of risks and uncertainties and there can be no assurance that any forward-looking statements will prove to be accurate. Various factors could cause actual results to differ materially from those anticipated in the forward-looking statements. CTI undertakes no obligation to update or revise any forward- looking statements. Further information regarding risks, uncertainties and other factors that could adversely affect CTI or cause actual results to differ materially from those anticipated in forward-looking statements are included in CTI's Annual Report on Form 10-K for the fiscal year ended September 30, 2003, Quarterly Report on Form 10-Q for the quarter ended March 31, 2004. DATASOURCE: CTI Molecular Imaging, Inc. and Mirada Solutions Ltd. CONTACT: Clare F. Jones of Mirada Solutions Ltd., Oxford, United Kingdom, +44 1865 265 500; or Michael A. Lawless of CTI Molecular Imaging, Inc., Knoxville, TN, +1-865-218-2000 Web site: http://www.ctimi.com/ http://www.mirada-solutions.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CTMI Cti Molecular Imaging - Common Stock (MM)